Infrapopliteal Referensi

 References

Allaqaband S, Kirvaitis R, Jan F, et al. Endovascular treatment of peripheral vascular disease. Curr Probl Cardiol. 2009;34:359-476.

Almasri J, Adusumalli J, Asi N, et al. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1S):S110-S119.

Bonaca MP, Nault P, Giugliano RP, et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: Insights from the FOURIER Trial (further cardiovascular outcomes research with pcsk9 inhibition in subjects with elevated risk). Circulation. 2018;137(4):338-350.

Bonaca MP, Bauersachs RM, Anand SS, et al. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med. 2020;382(21):1994-2004.

Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1S):S1-S109.e33.

Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med. 2017;377(14):1319-1330.

Farber A, Rosenfield K, Siami FS, Strong M, Menard M. The BEST-CLI trial is nearing the finish line and promises to be worth the wait. J Vasc Surg. 2019;69(2):470-481.e2.

Gabel J, Bianchi C, Possagnoli I, et al. Multidisciplinary approach achieves limb salvage without revascularization in patients with mild to moderate ischemia and tissue loss. J Vasc Surg. 2020;71(6):2073-2080.e1.

Geraghty PJ, Adams GL, Schmidt A, et al. Twelve-month results of Tack-optimized balloon angioplasty using the Tack Endovascular System in below-the-knee arteries (TOBA II BTK). J Endovasc Ther. 2020;27:626-636.

Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;69(11):1465-1508.

Gray WA, Jaff MR, Parikh SA, et al. Mortality assessment of paclitaxel-coated balloons: Patient-level meta-analysis of the ILLUMENATE clinical program at 3 years. Circulation. 2019;140(14):1145-1155.

Jongsma H, Bekken JA, Akkersdijk GP, et al. Angiosome-directed revascularization in patients with critical limb ischemia. J Vasc Surg. 2017;65(4):1208-1219.e1.

Khalili H, Jeon-Slaughter H, Armstrong EJ, et al. Atherectomy in below-the-knee endovascular interventions: One-year outcomes from the XLPAD registry. Catheter Cardiovasc Interv. 2019;93(3):488-493.

Müller-Hülsbeck S, Benko A, Soga Y, et al. Two-year efficacy and safety results from the IMPERIAL randomized study of the Eluvia polymer-coated drug-eluting stent and the Zilver PTX polymer-free drug-coated stent. Cardiovasc Intervent Radiol. 2021;44(3):368-375.

Mustapha JA, Finton SM, Diaz-Sandoval LJ, Saab FA, Miller LE. Percutaneous transluminal angioplasty in patients with infrapopliteal arterial disease: Systematic review and meta-analysis. Circ Cardiovasc Interv. 2016;9(5):e003468.

Mustapha JA, Katzen BT, Neville RF, et al. Disease burden and clinical outcomes following initial diagnosis of critical limb ischemia in the Medicare population. JACC Cardiovasc Interv. 2018;11(10):1011-1012.

Sachar R, Soga Y, Ansari MM, Kozuki A, et al. 1-year results from the RANGER II SFA randomized trial of the Ranger drug-coated balloon. JACC Cardiovasc Interv. 2021;14(10):1123-1133.

Schmidt A, Bakker OJ, Bausback Y, Scheinert D. The tibiopedal retrograde vascular access for challenging popliteal and below-the-knee chronic total occlusions: Literature review and description of the technique. J Cardiovasc Surg (Torino). 2017;58:371-82.

Skeik N, Nowariak ME, Smith JE, et al. Lipid-lowering therapies in peripheral artery disease: A review. Vasc Med. 2021;26(1):71-80.

Steiner S, Schmidt A, Zeller T, et al. COMPARE: Prospective, randomized, non-inferiority trial of high- vs. low-dose paclitaxel drug-coated balloons for femoropopliteal interventions. Eur Heart J. 2020;41(27):2541-2552.

Thompson JR, Henke PK. Contemporary management of critical limb ischemia. Adv Surg. 2018;52(1):257-274.

Venkatachalam S, Shishehbor MH, Gray BH. Basic data related to endovascular management of peripheral arterial disease in critical limb ischemia. Ann Vasc Surg. 2012; 26(7):1039-1051.

Walker CM, Mustapha J, Zeller T, et al. Tibiopedal access for crossing of infrainguinal artery occlusions: A prospective multicenter observational study. J Endovasc Ther. 2016;23:839-46.